Experimental drug offered to cancer patients with severe wasting
Symptom relief
NO_LONGER_AVAILABLE
This expanded access program gives seriously ill adults with advanced pancreatic cancer and cachexia (severe weight loss and muscle wasting) access to the experimental drug mifomelatide. Patients receive a daily injection for up to 13 weeks. The goal is to provide a potential tre…
Sponsor: Endevica Bio • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC